Home Open Care announces Immubio platform based on nanoparticle science, currently developing potential break-through COVID-19 immunisation Wesley-Cooke-Founder-and-CEO-Open-Care

Wesley-Cooke-Founder-and-CEO-Open-Care

Dr-Gustavo-Bracho-Chief-Immubio-Scientist-Open-Care